Quantbot Technologies LP Design Therapeutics, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.99 - $2.76 $4,378 - $6,071	-2,200 Reduced 56.34%	1,705 $4,000
Q3 2023 Nov 07, 2023	SELL	$2.05 - $8.14 $1,639 - $6,512	-800 Reduced 17.0%	3,905 $9,000
Q2 2023 Aug 08, 2023	SELL	$4.99 - $7.64 $30,678 - $46,970	-6,148 Reduced 56.65%	4,705 $29,000
Q1 2023 May 12, 2023	BUY	$5.5 - $9.77 $59,691 - $106,033	10,853 New	10,853 $62,000

103

30.8M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $277M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.